Blog Posts in May, 2015

  • Invokana And The Future Of SGLT-2s

    The FDA voted, in March 2013, to approve Invokana, a drug used in the treatment of Type 2 diabetes. The vote was 10 to five in favor of the approval for the drug developed by Janssen Pharmaceuticals ...
    Continue Reading
  • So-Called "Flushable Wipes": An Update

    In April of 2014, the Spangenberg law firm sued national retailer Target and manufacturer of non-woven fabrics Nice-Pak on behalf of individuals who had purchased Target Up+ Up Brand Flushable wipes ...
    Continue Reading
  • Michael Brelo Verdict

    Last Saturday, Cleveland Police Officer Michael Brelo was acquitted of voluntary manslaughter and felonious assault. The judge found the government proved beyond a reasonable doubt all the elements of ...
    Continue Reading
  • Heart Attack And Stroke A Result Of Diabetic Drug Invokana?

    Invokana, a relatively new drug used to treat Type 2 diabetes has recently come under fire for a number of potential risks associated with the drug. While much of the bad press regarding Invokana has ...
    Continue Reading
  • Health Canada Investigates Safety Of Invokana

    The FDA issued a safety communication in May 2015 regarding SGLT-2 inhibitor drugs such as Invokana, and the next month Health Canada began an investigation into the safety of SGLT-2 inhibitors. Like ...
    Continue Reading
  • Community Involvement

    Supporting the missions of various Ohio organizations along with our involvement in the Cleveland legal community has been a large part of Spangenberg Shibley & Liber's culture for the past 65 years. ...
    Continue Reading
Page of 1